Description | Replaces Chapter 70 and expands the program by which newborn infants are screened for certain conditions, enabling treatment and services to address those conditions. |
State Authority | None entered |
Federal Authority | None entered |
Text of Regulation | Link to Virginia Administrative Code |
Goals of Regulation | None entered |
Meetings | See all meetings (3) relating to this chapter. |
Name / Title: | Michael Capps / Sr. Policy Analyst |
Address: |
James Madison Building 109 Governor Street Richmond, VA 23219 |
Email Address: | boardofhealth@vdh.virginia.gov |
Telephone: | (804) 864-7190 FAX: (804)864-7022 TDD: ()- |
Current Actions | ||
Action Title | Latest Stage | Status |
---|---|---|
Amend Regulations Following Periodic Review | Fast-Track | Attorney General review in progress. |
Past Actions | ||
Action Title | Latest Stage | Status |
---|---|---|
Amend Regulations as a Result of Periodic Review | NOIRA | Stage complete. Comment period ended 01/04/2023. |
Amend Regulations to add SMA and X-ALD to the Virginia Newborn Screening System | Final | Stage complete. This regulation became effective on 03/16/2022. |
Amend regulations to add Pompe disease and mucopolysaccharidosis type 1 (MPS 1)
|
Final | Stage complete. This regulation became effective on 01/01/2019. |
Add Critical Congenital Heart Disease to the Virginia Newborn Screening System | Final | Stage complete. This regulation became effective on 10/20/2016. |
Amend regulations based on recommendations of VA Genetics Advisory Committee | Final | Stage complete. This regulation became effective on 06/04/2015. |
Amend Regulation as Result of Periodic Review | Fast-Track | Stage complete. This regulation became effective on 01/24/2014. |
Expansion of newborn screening services. | Final | Stage complete. This regulation became effective on 04/04/2007. |
Periodic Reviews | ||
Last Activity | Status | |
---|---|---|
7/29/2021 Agency Completed | Amend | |
3/21/2017 Agency Completed | Amend | |
2/8/2011 Agency Completed | Amend |